Data Helping Define Value-Based Care
Coordinated Care: The Value of Patient and Provider Satisfaction within Health System Specialty Pharmacies
Download this new white paper from IHOC - Coordinated Care: The Value of Patient and Provider Satisfaction within Health System Specialty Pharmacies - to learn the key insights about the role HSSPs play in improving the patient experience and why patient and provider satisfaction are important data points for both payers and manufacturers to consider when deciding to include HSSPs in their networks.
Integrating biosimilars into health systems pharmacies
Biosimilars are creating new opportunities for health systems, but also posing new challenges. Pharmacy leaders will need to address these three hurdles to successfully integrate biosimilars into the health system pharmacy.
Supply chain tip of the day: Understand biosimilar nuances before integrating them into the system
Biosimilars are creating new cost-saving opportunities for health system pharmacies, but before pharmacy leaders integrate biosimilars into their health system, they must understand their nuances.
Patient-Centered Care: The Case for Site Expansion to Include Health System Specialty Pharmacy
Health system specialty pharmacies are uniquely positioned to provide coordinated care to patients with complex and chronic conditions. With shared access to the patient's health record, multidisciplinary teams deliver integrated care that increases speed to therapy, enhances the patient experience and improves outcomes.
Supply chain tip of the day: Invest in professional development for your pharmacy staff
Hospital executives should promote and support the professional development of their pharmacy staffs, especially as PharmD program enrollment drops, C-suite positions for pharmacy leaders emerge and pharmacists begin to lead more strategic initiatives.
Supply chain tip of the day: Establish a specialty pharmacy strategy to improve operations
Hospital pharmacies are uniquely positioned to help health systems achieve greater operational efficiency and improve patient care. One way hospital pharmacies can drive new revenue streams, improve patient care and expel expenses is through establishing a specialty pharmacy strategy.
3 Key Considerations for Implementing Biosimilars in Health Systems
Rick Lozano, vice president of biosimilars and integrated business development for AmerisourceBergen, shares the three considerations for implementing biosimilars in the health system setting.
Implementing a Health-System Specialty Pharmacy
Willis Chandler, SVP & President, Health Systems & Specialty Services, AmerisourceBergen, showcases the many benefits of investing in an in-house specialty pharmacy, and thoughtfully walks through the process of evaluating the opportunity, formulating a plan, implementing the pharmacy, and ensuring access to distribution networks and payer contracts.
The case for the health system specialty pharmacy coordinated care model
Kristin Chambers, Vice President of Strategic Development, Integrated Health Systems Outcomes Coalition, shares the important benefits of clinical coordination, access opportunities/challenges and how health systems can build meaningful relationships with manufacturers.
Strategically Building a Health-System Specialty Pharmacy
Willis Chandler, SVP & President, Health Systems & Specialty Services, AmerisourceBergen, highlights how specialty pharmacies can help advance a health system’s strategic goals.
Biosimilars: Strategies for Utilization in the Health System Setting
As biosimilars enter the market, they have the potential to reshape the treatment landscape. In this informative webinar, leading experts will share how these options create opportunities for health system pharmacy leaders in this informative webinar.
Biosimilars: Key Considerations
As biosimilars launch, they are shaping the treatment landscape. These new options are also creating new opportunities for health system pharmacy leaders to expand their influence on patient outcomes.
Rethink: Channel Strategy for Oral Oncolytics
How manufacturers can benefit from provider-led care coordination to improve patient outcomes.
Upping the Game
How drug manufacturers, health systems and payers can collaborate more closely in the new world of patient-centered care.
Caring for the Whole Patient
What challenges does the increased demand for care coordination create for health system specialty pharmacies and what opportunities does it present for demonstrating value?